Advertisement
Singapore markets close in 2 hours 20 minutes

  • Straits Times Index

    3,307.07
    +3.88 (+0.12%)
     

  • Nikkei

    38,835.10
    +599.03 (+1.57%)
     

  • Hang Seng

    18,471.42
    -106.88 (-0.58%)
     

  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     

  • Bitcoin USD

    63,614.96
    -756.80 (-1.18%)
     

  • CMC Crypto 200

    1,366.76
    +1.63 (+0.12%)
     

  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     

  • Dow

    38,852.27
    +176.59 (+0.46%)
     

  • Nasdaq

    16,349.25
    +192.92 (+1.19%)
     

  • Gold

    2,327.30
    -3.90 (-0.17%)
     

  • Crude Oil

    78.57
    +0.09 (+0.11%)
     

  • 10-Yr Bond

    4.4890
    -0.0110 (-0.24%)
     

  • FTSE Bursa Malaysia

    1,609.36
    +11.97 (+0.75%)
     

  • Jakarta Composite Index

    7,133.85
    -2.04 (-0.03%)
     

  • PSE Index

    6,635.96
    -16.53 (-0.25%)
     

Novartis says bribe allegations in Turkey groundless, matter closed

Reuters

ZURICH (Reuters) - Swiss drugmaker Novartis said it was not under investigation over bribery allegations in Turkey and that it considered the matter closed.

"Based on thorough internal and external counsel investigations we have concluded that all recent publicly and anonymously reported allegations relating to Novartis Turkey are unsubstantiated. We are not aware of any government authority investigating Novartis. We now consider this matter closed," it said in an emailed statement on Friday.

The Ankara chief prosecutor's office had said in April it was investigating the Turkish unit of Novartis after allegations were made that the company benefited from bribery.

Novartis acknowledged on Thursday that six current or former employees in South Korea gave kickbacks to doctors including paying for their travel abroad.

(Reporting by Michael Shields; editing by Jason Neely)